Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TADA2A |
| Upstream (Parents) |
|---|
| (<<) NR4A3 → TADA2A |
| (<<) SIX6 → TADA2A |
| (<<) SHOX → TADA2A |
| (<<) HMG20B → TADA2A |
| (<<) SIM1 → TADA2A |
| (<<) TCF21 → TADA2A |
| (<<) TP73 → TADA2A |
| (<<) DBP → TADA2A |
| (<<) TRPS1 → TADA2A |
| (<<) JUND → TADA2A |
| Downstream (Children) |
|---|
| TADA2A → RUNX1 (>>) |
| TADA2A → BRD8 (>>) |
| TADA2A → FOXC2 (>>) |
| TADA2A → SIX3 (>>) |
| TADA2A → HIF3A (>>) |
| TADA2A → FOXI1 (>>) |
| TADA2A → TBX21 (>>) |
